Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18867141 | DIALYSIS SYSTEM HAVING ENHANCED VALVE FEATURES | November 2024 | April 2025 | Allow | 5 | 0 | 0 | No | No |
| 18893058 | PROCESS OF PURIFICATION OF PROTEIN | September 2024 | January 2025 | Allow | 4 | 0 | 0 | No | No |
| 18824560 | KITCHEN WASTE WASTEWATER TREATMENT EQUIPMENT | September 2024 | October 2024 | Allow | 2 | 0 | 0 | No | No |
| 18805922 | INTEGRATED RAPID TREATMENT SYSTEM FOR NUCLEAR MEDICAL RADIOACTIVE WASTEWATER AND APPLICATION METHOD THEREOF | August 2024 | October 2024 | Allow | 2 | 0 | 0 | No | No |
| 18797446 | SULFUR-MOLYBDENUM CLUSTER MODIFIED MOF MATERIAL AND PREPARATION METHOD AND APPLICATION THEREOF | August 2024 | October 2024 | Allow | 2 | 0 | 0 | No | No |
| 18756677 | PRASEODYMIUM-DOPED UPCONVERSION PHOSPHOR | June 2024 | September 2024 | Allow | 3 | 0 | 0 | No | No |
| 18747386 | Outdoor Water Purifier | June 2024 | September 2024 | Allow | 3 | 0 | 0 | No | No |
| 18653906 | COMPOSITIONS AND METHODS FOR PLASMAPHERESIS | May 2024 | October 2024 | Allow | 5 | 0 | 1 | No | No |
| 18653903 | COMPOSITIONS AND METHODS FOR PLASMAPHERESIS | May 2024 | February 2025 | Allow | 9 | 2 | 0 | Yes | No |
| 18651805 | SYSTEM AND PROCESS FOR REDUCING PFAS AND MICROPLASTICS IN BIOSOLIDS USING HYDRODYNAMIC CAVITATION AND FOAM FRACTIONATION | May 2024 | January 2025 | Allow | 9 | 0 | 1 | No | No |
| 18648343 | Membrane Fouling Early Warning Method and Device Based on Machine Learning | April 2024 | July 2024 | Allow | 3 | 0 | 0 | No | No |
| 18631965 | FILTER ELEMENT MOUNTING STRUCTURE | April 2024 | June 2024 | Allow | 2 | 0 | 0 | No | No |
| 18619120 | DEVICE FOR TREATING URANIUM TAILINGS WITH MICROORGANISM | March 2024 | July 2024 | Allow | 4 | 0 | 0 | No | No |
| 18605528 | Hemofilter For In Vivo Blood Filtration | March 2024 | February 2025 | Allow | 11 | 1 | 0 | No | No |
| 18595901 | METHOD AND SYSTEM FOR SUSTAINABLE BRINE TREATMENT AND HEAVY METAL PURIFICATION USING RECYCLED CARBON FIBER | March 2024 | August 2024 | Allow | 5 | 0 | 1 | No | No |
| 18595191 | APPARATUS FOR SUPPLEMENTING FUNCTION OF ENDOCRINE GLANDS | March 2024 | May 2025 | Allow | 14 | 1 | 0 | No | No |
| 18584581 | TRI-METALLIC ORGANIC FRAMEWORK (MOF) COMPLEX AS A REDUCTION CATALYST | February 2024 | June 2024 | Allow | 4 | 0 | 1 | No | No |
| 18407456 | WATER PURIFICATION, STERILIZATION AND DISINFECTION LAMP | January 2024 | April 2024 | Allow | 3 | 0 | 0 | No | No |
| 18577901 | APPARATUS AND PROCESS FOR REMOVING PFAS AND PFAS COMPOUNDS FROM WATER | January 2024 | June 2024 | Allow | 5 | 0 | 0 | No | No |
| 18400507 | ABSOLUTE BLOOD VOLUME ESTIMATION DEVICE AND METHOD | December 2023 | November 2024 | Allow | 11 | 0 | 0 | No | No |
| 18491072 | DEVICE FOR FORMING A MEDICAL PASTE | October 2023 | August 2024 | Allow | 10 | 1 | 0 | No | No |
| 18287800 | COMPOSITE SEMIPERMEABLE MEMBRANE | October 2023 | July 2024 | Allow | 8 | 1 | 0 | No | No |
| 18456122 | ELECTRICAL PLUG FOR A DIALYSIS MACHINE | August 2023 | August 2024 | Allow | 12 | 1 | 0 | No | No |
| 18452516 | HEMODIALYSIS SYSTEMS AND METHODS | August 2023 | April 2024 | Allow | 8 | 0 | 0 | No | No |
| 18365090 | DEVICES FOR EFFICIENT SORBENT UTILIZATION IN LITHIUM EXTRACTION | August 2023 | January 2024 | Allow | 6 | 0 | 0 | No | No |
| 18358840 | BLOOD CIRCUIT ASSEMBLY FOR A HEMODIALYSIS SYSTEM | July 2023 | February 2024 | Allow | 7 | 0 | 0 | No | No |
| 18224127 | Treatment Fluid Multi-Stream Blood Warmer | July 2023 | August 2024 | Allow | 13 | 0 | 1 | No | No |
| 18219938 | SYSTEM AND METHOD FOR CARDIOPULMONARY BYPASS USING HYPOBARIC OXYGENATION | July 2023 | February 2024 | Allow | 8 | 0 | 0 | No | No |
| 18346174 | BLOOD TREATMENT SYSTEMS AND METHODS | June 2023 | July 2024 | Allow | 13 | 2 | 0 | No | No |
| 18269652 | PERITONEAL DIALYSIS SYSTEM HAVING DISINFECTION FLUID PUMPING AND PATHWAY | June 2023 | October 2023 | Allow | 4 | 0 | 0 | No | No |
| 18211778 | AUTOMATIC PLASMA SEPARATION AND METERING | June 2023 | February 2025 | Allow | 20 | 1 | 1 | No | No |
| 18204305 | COMPOSITIONS AND METHODS FOR PLASMAPHERESIS | May 2023 | March 2024 | Allow | 10 | 1 | 1 | No | No |
| 18204306 | COMPOSITIONS AND METHODS FOR PLASMAPHERESIS | May 2023 | August 2024 | Allow | 14 | 3 | 1 | Yes | No |
| 18204293 | COMPOSITIONS AND METHODS FOR PLASMAPHERESIS | May 2023 | February 2024 | Allow | 9 | 1 | 1 | Yes | No |
| 18323055 | Blood Processing Apparatus and Method for Detoxifying Bacterial Lipopolysaccharide In Vivo | May 2023 | April 2024 | Allow | 11 | 1 | 1 | No | No |
| 18323077 | Blood Processing Apparatus and Method forDestroying Cancer Metastasis In Vivo | May 2023 | April 2024 | Allow | 11 | 1 | 1 | No | No |
| 18200119 | WEARABLE MODULAR EXTRACORPOREAL LIFE SUPPORT DEVICE FOR MOBILE TREATMENT OF SINGLE AND MULTIORGAN FAILURE | May 2023 | August 2024 | Allow | 15 | 1 | 1 | No | No |
| 18143733 | Blood Treatment Device Priming Devices, Methods, and Systems | May 2023 | December 2023 | Allow | 8 | 0 | 1 | No | No |
| 18138711 | CASSETTE SYSTEM INTEGRATED APPARATUS | April 2023 | March 2024 | Allow | 10 | 1 | 0 | No | No |
| 18130635 | BLOOD PLASMA SEPARATION DEVICE | April 2023 | November 2023 | Allow | 8 | 0 | 0 | No | No |
| 18171637 | EXTRACORPOREAL BLOOD FILTERING MACHINE AND METHODS | February 2023 | July 2023 | Allow | 5 | 0 | 0 | No | No |
| 18171640 | EXTRACORPOREAL BLOOD FILTERING MACHINE AND METHODS | February 2023 | March 2024 | Allow | 13 | 2 | 1 | No | No |
| 18171636 | EXTRACORPOREAL BLOOD FILTERING MACHINE AND METHODS | February 2023 | January 2024 | Allow | 11 | 2 | 0 | No | No |
| 18109547 | SYSTEMS AND METHODS FOR OPTIMIZATION OF PLASMA COLLECTION VOLUMES | February 2023 | June 2023 | Allow | 4 | 2 | 0 | No | No |
| 18103458 | CONTROL SYSTEMS AND METHODS FOR BLOOD OR FLUID HANDLING MEDICAL DEVICES | January 2023 | February 2024 | Allow | 13 | 2 | 0 | No | No |
| 18017619 | PRESSURE SENSORS, INCLUDING PRESSURE SENSORS FOR AUTOMATED PERITONEAL DIALYSIS SYSTEMS, AND ASSOCIATED SYSTEMS, DEVICES, AND METHODS | January 2023 | July 2025 | Allow | 29 | 0 | 0 | No | No |
| 18094820 | ULTRAPURE WATER SUPPLY APPARATUS, SUBSTRATE PROCESSING SYSTEM INCLUDING THE SAME, AND SUBSTRATE PROCESSING METHOD USING THE SAME | January 2023 | August 2024 | Allow | 19 | 0 | 1 | No | No |
| 18081375 | PERITONEAL DIALYSIS SYSTEM HAVING CARBON DIOXIDE INJECTION TO INHIBIT/REMOVE CALCIUM CARBONATE | December 2022 | April 2025 | Allow | 28 | 0 | 0 | No | No |
| 18059181 | PERITONEAL DIALYSIS SYSTEM AND METHODS | November 2022 | November 2023 | Allow | 12 | 0 | 0 | No | No |
| 17927141 | PERITONEAL DIALYSIS USING PRESSURIZED CHAMBER | November 2022 | June 2025 | Allow | 31 | 0 | 1 | No | No |
| 17927135 | PERITONEAL DIALYSIS USING PRESSURIZED CYLINDER | November 2022 | April 2025 | Allow | 28 | 0 | 0 | No | No |
| 17986397 | Hemofilter For In Vivo Blood Filtration | November 2022 | December 2023 | Allow | 13 | 1 | 0 | No | No |
| 17984408 | Microfluidic Diffusion Devices And Systems, And Methods Of Manufacturing And Using Same | November 2022 | January 2025 | Allow | 26 | 2 | 0 | No | No |
| 17983668 | PERITONEAL DIALYSIS CYCLER HAVING DISINFECTION | November 2022 | June 2025 | Allow | 31 | 0 | 1 | No | No |
| 17981635 | PERITONEAL DIALYSIS CYCLER HAVING DISINFECTION | November 2022 | June 2025 | Allow | 31 | 0 | 1 | No | No |
| 17977785 | Self-Sealing Fluid Connectors | October 2022 | May 2025 | Allow | 30 | 0 | 1 | No | No |
| 17974364 | BLOOD TREATMENT SYSTEMS AND METHODS | October 2022 | March 2023 | Allow | 4 | 0 | 0 | No | No |
| 17974023 | System for Tailoring Dialysis Treatment Based on Sensed Potassium Concentration, Patient Data, and Population Data | October 2022 | October 2023 | Allow | 12 | 1 | 0 | No | No |
| 17920584 | MEASUREMENT AND AUTOMATED PERITONEAL DIALYSIS APPARATUS AND METHOD THEREFOR | October 2022 | March 2025 | Allow | 29 | 0 | 0 | No | No |
| 17959147 | GAS TREATMENT DELIVERY SYSTEMS AND METHODS | October 2022 | November 2024 | Abandon | 25 | 3 | 0 | No | Yes |
| 17943377 | TECHNIQUES FOR REMOVING BOUND TARGET SUBSTANCES DURING DIALYSIS | September 2022 | January 2024 | Allow | 16 | 0 | 0 | No | No |
| 17909013 | SYSTEM AND METHOD FOR MONITORING SEMICONDUCTOR PROCESSES | September 2022 | November 2024 | Allow | 26 | 1 | 1 | No | No |
| 17905413 | Extracorporeal oxygenation system for low flow rates and methods of use | September 2022 | March 2023 | Allow | 7 | 0 | 0 | No | No |
| 17892973 | SORBENT FOR A DIALYSIS DEVICE AND DIALYSIS SYSTEM | August 2022 | February 2025 | Allow | 29 | 1 | 2 | No | No |
| 17888262 | BIOLOGICAL FLUID PURIFICATION WITH BIOCOMPATIBLE MEMBRANES | August 2022 | October 2023 | Allow | 14 | 1 | 0 | No | No |
| 17797074 | Connector for Creating Platelet Rich Plasma | August 2022 | May 2024 | Allow | 21 | 1 | 1 | Yes | No |
| 17873798 | SYSTEM FOR CONCENTRATING PHOSPHOLIPIDS | July 2022 | May 2025 | Allow | 33 | 1 | 1 | No | No |
| 17814539 | APPARATUS UTILIZING ELECTRIC FIELD FOR PROCESSING OF BLOOD TO NEUTRALIZE PATHOGEN CELLS THEREIN | July 2022 | March 2025 | Allow | 32 | 0 | 0 | No | No |
| 17788855 | CRUSHING DEVICE AND WASTE TREATMENT DEVICE | June 2022 | March 2025 | Abandon | 33 | 1 | 1 | No | No |
| 17843950 | MODIFIED TNF AS A CAPTURE LIGAND | June 2022 | February 2024 | Allow | 20 | 2 | 1 | No | No |
| 17838902 | CUSTOM DATA FIELDS FOR AUTOMATED APHERESIS PROCEDURES | June 2022 | October 2023 | Allow | 16 | 1 | 1 | No | No |
| 17825918 | SYSTEMS AND METHODS FOR OPTIMIZATION OF PLASMA COLLECTION VOLUMES | May 2022 | July 2024 | Allow | 26 | 1 | 1 | No | No |
| 17777590 | A BIOPROCESS FLUID MIXING SYSTEM | May 2022 | March 2025 | Allow | 34 | 1 | 0 | No | No |
| 17745161 | FILTER BOWL RETENTION MECHANISM | May 2022 | June 2024 | Allow | 25 | 1 | 0 | No | No |
| 17743167 | SYRINGE-BASED MANUAL EXTRACORPOREAL BLOOD TREATMENT SYSTEMS AND METHODS EMPLOYING BATCH PROCESSING | May 2022 | March 2025 | Allow | 34 | 1 | 0 | No | No |
| 17738420 | AUTOMATED PERITONEAL DIALYSIS SYSTEM HAVING A DRAIN PURGE | May 2022 | March 2025 | Allow | 34 | 0 | 0 | No | No |
| 17738368 | AUTOMATED PERITONEAL DIALYSIS SYSTEM HAVING A DISPOSABLE CASSETTE AND VALVE SEAT THEREFORE | May 2022 | March 2025 | Allow | 34 | 0 | 0 | No | No |
| 17738276 | AUTOMATED PERITONEAL DIALYSIS SYSTEM HAVING LOAD CELL CALIBRATION | May 2022 | February 2025 | Allow | 34 | 0 | 0 | No | No |
| 17737611 | Membrane System to Treat Leachate and Methods of Treating Leachate | May 2022 | August 2023 | Allow | 16 | 2 | 0 | No | No |
| 17731054 | ISOPOROUS SELF-ASSEMBLED BLOCK COPOLYMER FILMS CONTAINING HIGH MOLECULAR WEIGHT HYDROPHILIC ADDITIVES AND METHODS OF MAKING THE SAME | April 2022 | June 2023 | Allow | 14 | 1 | 0 | No | No |
| 17716434 | ELECTRICAL PLUG FOR A MEDICAL DEVICE | April 2022 | May 2023 | Allow | 14 | 1 | 0 | No | No |
| 17766536 | PRINTABLE ELECTRICAL COMPONENT COMPRISING A PLASTIC SUBSTRATE | April 2022 | May 2023 | Allow | 13 | 1 | 1 | No | No |
| 17696546 | Medicament Preparation Devices, Methods, and Systems | March 2022 | April 2025 | Allow | 37 | 0 | 1 | No | No |
| 17675824 | SYSTEMS AND METHODS FOR OPTIMIZATION OF PLASMA COLLECTION VOLUMES | February 2022 | May 2022 | Allow | 3 | 1 | 0 | No | No |
| 17590890 | NANOBIOCATALYST AND NANOBIOCATALYTIC MEMBRANE | February 2022 | September 2023 | Allow | 20 | 2 | 0 | No | No |
| 17577248 | REDUCED LEACHING OF A LIGAND | January 2022 | August 2024 | Abandon | 31 | 3 | 0 | No | No |
| 17626653 | METHOD FOR CLEANING ELECTROPHORETIC COATING BATHS, AND DEVICE THEREFOR | January 2022 | February 2025 | Allow | 37 | 0 | 0 | No | No |
| 17626409 | Device for Capturing and Removing Magnetic Material From a Flow of Material | January 2022 | August 2024 | Allow | 31 | 0 | 0 | No | No |
| 17570906 | SYSTEM FOR REMOVING UREMIC TOXINS IN DIALYSIS PROCESSES | January 2022 | October 2023 | Allow | 21 | 1 | 1 | No | No |
| 17569738 | Bone Marrow Adipose Portion Isolation Device and Methods | January 2022 | October 2024 | Allow | 33 | 4 | 1 | No | No |
| 17568680 | HEMODIALYSIS SYSTEM WITH DIALYSATE RECYCLING | January 2022 | June 2023 | Abandon | 17 | 3 | 0 | No | No |
| 17563926 | PERITONEAL DIALYSIS SYSTEM AND METHOD HAVING INTRAPERITONEAL PRESSURE SENSING | December 2021 | November 2024 | Allow | 35 | 0 | 0 | No | No |
| 17563651 | Peritoneal Dialysis System with Constant Volume Disposable Pump | December 2021 | May 2025 | Allow | 40 | 0 | 1 | No | No |
| 17559792 | VENTING OR DEGASSING OF FILTER DEVICES AND FILTRATION SYSTEMS | December 2021 | April 2024 | Abandon | 28 | 2 | 1 | No | No |
| 17618460 | CLOG FREE CONDENSATION SYSTEM FOR PYROLYSIS VAPOR OF PET CONTAINING POLYMER | December 2021 | November 2024 | Abandon | 35 | 1 | 0 | No | No |
| 17618268 | METHOD AND DEVICE FOR CONTROLLING MOVEMENT OF MICRO-PARTICLES IN SOLUTION USING ULTRA-HIGH FREQUENCY SOUND WAVE | December 2021 | January 2025 | Allow | 37 | 1 | 1 | No | No |
| 17617494 | SUPERCRITICAL FLUID CHROMATOGRAPH AND SAMPLE SUPPLY METHOD USED IN SUPERCRITICAL FLUID CHROMATOGRAPH | December 2021 | June 2025 | Allow | 43 | 1 | 0 | Yes | No |
| 17617059 | AMINE SEPARATION METHOD USING LIQUID CHROMATOGRAPHY | December 2021 | August 2024 | Allow | 32 | 1 | 0 | No | No |
| 17530087 | HYDROCARBON FLUID-WATER SEPARATION | November 2021 | May 2023 | Allow | 18 | 1 | 0 | No | No |
| 17527844 | PORTABLE WATER QUALITY INSTRUMENT | November 2021 | March 2023 | Allow | 16 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner KIM, SUN U.
With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 37.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner KIM, SUN U works in Art Unit 1777 and has examined 963 patent applications in our dataset. With an allowance rate of 82.1%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 31 months.
Examiner KIM, SUN U's allowance rate of 82.1% places them in the 48% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by KIM, SUN U receive 1.50 office actions before reaching final disposition. This places the examiner in the 36% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by KIM, SUN U is 31 months. This places the examiner in the 35% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +8.5% benefit to allowance rate for applications examined by KIM, SUN U. This interview benefit is in the 41% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 31.3% of applications are subsequently allowed. This success rate is in the 56% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 44.8% of cases where such amendments are filed. This entry rate is in the 62% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 111.1% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 78% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 95.5% of appeals filed. This is in the 84% percentile among all examiners. Of these withdrawals, 52.4% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 50.6% are granted (fully or in part). This grant rate is in the 62% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 4.2% of allowed cases (in the 87% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 8.8% of allowed cases (in the 86% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.